Preview
Should all patients with congestive heart failure and ventricular arrhythmias receive prophylactic antiarrhythmic drug therapy? What are the potential risks of such therapy? Dr Ravid discusses the findings of recent and ongoing studies of antiarrhythmic agents and presents practical guidelines for use of these drugs in patients with heart failure.